HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Oliveras-Ferraros Selected Research

Iridoids

2/2013Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.
6/2011Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
9/2010Prediction of extra virgin olive oil varieties through their phenolic profile. Potential cytotoxic activity against human breast cancer cells.
1/2010Characterization and quantification of phenolic compounds of extra-virgin olive oils with anticancer properties by a rapid and resolutive LC-ESI-TOF MS method.
1/2009Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
10/2008Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Oliveras-Ferraros Research Topics

Disease

47Neoplasms (Cancer)
04/2014 - 10/2008
34Breast Neoplasms (Breast Cancer)
01/2014 - 01/2008
8Carcinoma (Carcinomatosis)
04/2013 - 01/2009
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2013 - 12/2011
4Neoplasm Metastasis (Metastasis)
04/2013 - 11/2010
3Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 01/2011
3Carcinogenesis
12/2011 - 03/2009
2Inflammation (Inflammations)
04/2014 - 01/2009
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2012 - 12/2011
2Fibrosis (Cirrhosis)
02/2012 - 11/2010
2Type 2 Diabetes Mellitus (MODY)
12/2011 - 11/2010
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2011 - 05/2011
2Disease Progression
08/2010 - 12/2009
1Stomach Neoplasms (Stomach Cancer)
04/2014
1Polyploidy
01/2014
1Genomic Instability
01/2014
1Lung Neoplasms (Lung Cancer)
11/2013
1Starvation
07/2012
1Teratoma (Teratoid Tumor)
01/2012
1Teratocarcinoma
01/2012
1Squamous Cell Carcinoma of Head and Neck
12/2011

Drug/Important Bio-Agent (IBA)

20Metformin (Glucophage)FDA LinkGeneric
01/2014 - 01/2009
12Trastuzumab (Herceptin)FDA Link
01/2013 - 07/2009
9Proteins (Proteins, Gene)FDA Link
04/2014 - 10/2008
8Pharmaceutical PreparationsIBA
02/2012 - 01/2009
7BiguanidesIBA
01/2014 - 07/2009
6IridoidsIBA
02/2013 - 10/2008
6Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2013 - 10/2008
6Monoclonal AntibodiesIBA
01/2013 - 07/2009
6Hypoglycemic Agents (Hypoglycemics)IBA
07/2012 - 01/2009
5PolyphenolsIBA
11/2013 - 10/2008
5Biomarkers (Surrogate Marker)IBA
01/2013 - 01/2009
5Cetuximab (Erbitux)FDA Link
06/2012 - 12/2008
5Olive OilIBA
06/2012 - 10/2008
4Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2013 - 06/2011
4Tyrosine Kinase InhibitorsIBA
11/2013 - 07/2009
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2012 - 10/2008
4LignansIBA
06/2011 - 10/2008
3Silybin (Lagosa)IBA
11/2013 - 01/2013
3Gefitinib (Iressa)FDA Link
10/2013 - 12/2008
3Phenobarbital (Luminal)FDA Link
09/2013 - 11/2012
3EnzymesIBA
01/2013 - 10/2008
3Insulin (Novolin)FDA Link
01/2013 - 11/2009
3MicroRNAs (MicroRNA)IBA
01/2013 - 04/2011
3Glucose (Dextrose)FDA LinkGeneric
08/2012 - 03/2010
3Phosphotransferases (Kinase)IBA
07/2012 - 03/2009
3DNA (Deoxyribonucleic Acid)IBA
03/2012 - 01/2008
3Lapatinib (GW572016)FDA Link
06/2011 - 07/2009
3Histones (Histone)IBA
06/2011 - 03/2009
3TOR Serine-Threonine KinasesIBA
01/2010 - 03/2009
2ErbB Receptors (EGF Receptor)IBA
01/2013 - 12/2008
2Cadherins (E-Cadherin)IBA
01/2013 - 11/2010
2Transcription Factors (Transcription Factor)IBA
11/2012 - 09/2010
2AMP-Activated Protein KinasesIBA
08/2012 - 03/2009
2PhenolsIBA
06/2012 - 06/2011
2Messenger RNA (mRNA)IBA
04/2012 - 12/2009
2Adenosine Triphosphate (ATP)IBA
03/2012 - 01/2009
2LigandsIBA
12/2011 - 01/2011
2AntibodiesIBA
03/2010 - 12/2008
2Serine (L-Serine)FDA Link
01/2010 - 03/2009
2polypeptide 1 70kD ribosomal protein S6 kinaseIBA
07/2009 - 01/2009
1Estrogens (Estrogen)FDA Link
01/2014
1Peptide Hydrolases (Proteases)FDA Link
01/2014
1Aurora Kinase AIBA
01/2014
1Amino SugarsIBA
10/2013
1SilymarinIBA
10/2013
1milk-thistle extractIBA
10/2013
1MeglumineFDA Link
10/2013
1Complement System Proteins (Complement)IBA
04/2013
1Biological ProductsIBA
01/2013
1Proton-Translocating ATPases (ATPase, H+)IBA
01/2013
1Acetyl-CoA CarboxylaseIBA
01/2013
1Chloroquine (Aralen)FDA LinkGeneric
01/2013
1Antimalarials (Antimalarial Agents)IBA
01/2013
1Staphylococcal Protein A (Protein A)IBA
01/2013
1Oxygen (Dioxygen)IBA
08/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2012
1CarbonIBA
07/2012
1HypoxanthineIBA
07/2012
1Folic Acid AntagonistsIBA
07/2012
1ThymidineIBA
07/2012
15,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA
07/2012
1PurinesIBA
07/2012
1PyrimidinesIBA
07/2012
1catechol (pyrocatechol)IBA
06/2012
1TransferasesIBA
06/2012
1EpiregulinIBA
04/2012
1AmphiregulinIBA
04/2012
1I-antigenIBA
03/2012
1Succinate Dehydrogenase (Fumarate Reductase)IBA
03/2012
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
03/2012
1InterferonsIBA
12/2011

Therapy/Procedure

13Therapeutics
01/2013 - 07/2009
3Drug Therapy (Chemotherapy)
03/2010 - 01/2008
2Aftercare (After-Treatment)
01/2014 - 04/2011
2Mediterranean Diet
06/2012 - 12/2008
2Caloric Restriction
10/2010 - 03/2010
1Subcutaneous Injections
12/2012
1Precision Medicine
06/2012
1Transplantation
01/2012